These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21889716)

  • 1. Hormonal mechanisms underlying the relationship between obesity and breast cancer.
    Perks CM; Holly JM
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):485-507, vii. PubMed ID: 21889716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen carcinogenesis in breast cancer.
    Germain D
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):473-84, vii. PubMed ID: 21889715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between menopausal status and obesity in affecting breast cancer risk.
    Rose DP; Vona-Davis L
    Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.
    Lee AV; Cui X; Oesterreich S
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4429s-4435s; discussion 4411s-4412s. PubMed ID: 11916236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and obesity: an update.
    Stephenson GD; Rose DP
    Nutr Cancer; 2003; 45(1):1-16. PubMed ID: 12791499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities.
    Massarweh S; Schiff R
    Clin Cancer Res; 2007 Apr; 13(7):1950-4. PubMed ID: 17404074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and cancer risk: the role of the insulin-IGF axis.
    Renehan AG; Frystyk J; Flyvbjerg A
    Trends Endocrinol Metab; 2006 Oct; 17(8):328-36. PubMed ID: 16956771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular contribution of TNF-α in the link between obesity and breast cancer.
    Weichhaus M; Broom I; Bermano G
    Oncol Rep; 2011 Feb; 25(2):477-83. PubMed ID: 21165572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.
    Fuentes-Mattei E; Velazquez-Torres G; Phan L; Zhang F; Chou PC; Shin JH; Choi HH; Chen JS; Zhao R; Chen J; Gully C; Carlock C; Qi Y; Zhang Y; Wu Y; Esteva FJ; Luo Y; McKeehan WL; Ensor J; Hortobagyi GN; Pusztai L; Fraser Symmans W; Lee MH; Yeung SC
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24957076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of obesity on breast cancer receptor status and prognosis.
    Rose DP; Vona-Davis L
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1091-101. PubMed ID: 19671029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.
    Perrier S; Caldefie-Chézet F; Vasson MP
    FEBS Lett; 2009 Jan; 583(2):259-65. PubMed ID: 19111549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of obesity on breast cancer development.
    Cleary MP; Grossmann ME; Ray A
    Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological mechanisms linking obesity and cancer risk: new perspectives.
    Roberts DL; Dive C; Renehan AG
    Annu Rev Med; 2010; 61():301-16. PubMed ID: 19824817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review).
    Rose DP; Gilhooly EM; Nixon DW
    Int J Oncol; 2002 Dec; 21(6):1285-92. PubMed ID: 12429979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
    Massarweh S; Schiff R
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between estrogen and leptin signaling in the hypothalamus.
    Gao Q; Horvath TL
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E817-26. PubMed ID: 18334610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer.
    Rizzo P; Osipo C; Pannuti A; Golde T; Osborne B; Miele L
    Adv Enzyme Regul; 2009; 49(1):134-41. PubMed ID: 19344631
    [No Abstract]   [Full Text] [Related]  

  • 20. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast.
    Donegan WL; Johnstone MF; Biedrzycki L
    Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.